Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, previously known as Tianjin Zhong Xin Pharmaceutical Group, held its second extraordinary general meeting for FY2024. The meeting took place in Tianjin, China, with simultaneous video conferencing for international shareholders in Singapore. This gathering reflects the company’s commitment to engaging with its global shareholder base.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Nike Q2 Earnings Preview: Analysts Expect a Decline in Earnings and Sales
- Salesforce Hits 1,000 Agentforce Deals, Launches Agentforce 2.0
- Starbucks’ Union Threatens Strike at the 11th Hour
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
